« Return to News | Technology Solutions

endpoint Clinical and OmniComm partner

Wednesday, April 13, 2011 02:01 PM

endpoint Clinical, a developer of Integrated Voice Response (IVR)/Integrated Web Response (IWR) systems, has partnered with OmniComm Systems, and electronic data capture (EDC) company, to provide an integrated method of capturing and transferring data for clinical trials that reduces redundancy in data entry and improves the speed at which a clinical trial can take place.

endpoint’s flagship product platform, PULSE, is fully configurable, allowing users to design and deploy clinical trial Integrated Response Technology (IRT) systems and save time developing clinical trials.

The IVR/EDC integration aims to reduce the number of systems that access the data, eliminate duplicate data entry through the sharing of data, streamline the flow of information and enable dual site activation by exchanging data for screening. 

 “We are very happy to be working with endpoint to offer our customers an integrated solution to improve clinical trial efficiency, reduce timelines, and drive down operational costs,” said Stephen Johnson, president and COO of OmniComm. “By working together, we allow program managers to spend more time managing a study with less time spent trying to manage the data.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.